These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 14769212

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41.
    Liu S, Lu H, Zhao Q, He Y, Niu J, Debnath AK, Wu S, Jiang S.
    Biochim Biophys Acta; 2005 May 25; 1723(1-3):270-81. PubMed ID: 15823507
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M, Lemay G, Cohen EA.
    Virus Res; 2007 Mar 25; 124(1-2):103-12. PubMed ID: 17129629
    [Abstract] [Full Text] [Related]

  • 28. [Inhibitory effect of polysaccharides on the six-alpha-helix bundle formation of HIV gp41 protein].
    Wen XY, Wu SY, Xu W, Lv L, Liu SW, Rao JJ, Zhang JJ, Wang GF, Wan SH, Wu SG.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct 25; 27(10):1498-500. PubMed ID: 17959523
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Anti-HIV-1 effect of compound K3 from flower of Japanese pagoda tree in vitro].
    Zhang GH, Zheng YT.
    Zhong Yao Cai; 2006 Apr 25; 29(4):355-8. PubMed ID: 16913492
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
    Gustchina E, Hummer G, Bewley CA, Clore GM.
    J Med Chem; 2005 Apr 21; 48(8):3036-44. PubMed ID: 15828842
    [Abstract] [Full Text] [Related]

  • 34. Design, synthesis and biological evaluation of 3-substituted 2,5-dimethyl-N-(3-(1H-tetrazol-5-yl)phenyl)pyrroles as novel potential HIV-1 gp41 inhibitors.
    He XY, Zou P, Qiu J, Hou L, Jiang S, Liu S, Xie L.
    Bioorg Med Chem; 2011 Nov 15; 19(22):6726-34. PubMed ID: 22014749
    [Abstract] [Full Text] [Related]

  • 35. Anti-HIV-1 Activity Prediction of Novel Gp41 Inhibitors Using Structure-Based Virtual Screening and Molecular Dynamics Simulation.
    Sepehri S, Saghaie L, Fassihi A.
    Mol Inform; 2017 Mar 15; 36(3):. PubMed ID: 27730744
    [Abstract] [Full Text] [Related]

  • 36. Anti-HIV-1 activity of trichobitacin, a novel ribosome-inactivating protein.
    Zheng YT, Ben KL, Jin SW.
    Acta Pharmacol Sin; 2000 Feb 15; 21(2):179-82. PubMed ID: 11263268
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Making strides in peptide-based therapeutics.
    Guarracino DA, Arora PS.
    Chem Biol; 2009 Sep 25; 16(9):919-20. PubMed ID: 19778718
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.